L'Oréal Partners with Sanofi and Novartis at CIIE to Advance Dermatological Public Health Initiatives and Build a Skin Barrier Ecosystem

Building a Skin Barrier Ecosystem, Empowering "Beautiful Holistic Health"

ShanghaiNovember 7, 2023PR Newswire -- At the 6th China International Import Expo, L'Oréal China announced public welfare collaborations with Sanofi China and Novartis China respectively. CeraVe, a brand under L'Oréal, and Dupixent, a brand under Sanofi, jointly held the "Joining Hands for Love, Co-creating a New Life" strategic cooperation signing ceremony. Meanwhile, CeraVe and Novartis convened the "Integrated Treatment and Care, Advancing Towards the 'Beautiful Greater Health' Ecosystem" strategic cooperation upgrade conference, further deepening multi-dimensional public welfare initiatives. This series of collaborations aims to leverage the professional expertise of all parties in the field of dermatological science, promote the deep integration of the beauty and health industries, and work hand-in-hand with leading industry partners to build a skin barrier ecosystem, contributing to the realization of the "Beautiful Greater Health" blueprint.

In积极响应 to the "Healthy China 2030" planning outline, L'Oréal has gained deep insights into trends in the beauty and health industries. In 2022, L'Oréal released its "Beautiful Greater Health" initiative for the first time, proposing 10 measures around three key areas: innovation-driven transformation, ecosystem empowerment, and social responsibility implementation. These aim to integrate industry forces and build a "Beautiful Greater Health" ecosystem. This past March, L'Oréal's Active Health Cosmetics Division was renamed the L'Oréal Dermatological Beauty Division, with dermatological science as its foundation. It is committed to leading "healthy beauty" through scientific and professional skincare solutions and opening up collaboration opportunities for "Beautiful Greater Health" through its four major brands. This year marks the fifth anniversary of CeraVe’s entry into China at the first China International Import Expo (CIIE). On this occasion, CeraVe has partnered with two leading pharmaceutical companies, Sanofi and Novartis, to deepen co-creation mechanisms in areas such as dermatological research, patient assistance, and health education, sharing the beauty of health with more patients suffering from skin diseases and the broader public.

 "Join Hands for Love, Reshape a New Life": L'Oréal Partners with Sanofi in a Philanthropic Initiative to Promote Scientific Management of the Skin Barrier Process

L'Oréal and Sanofi "Join Hands for Love, Co-create a New Life" Cross-border Public Welfare Cooperation Signing Ceremony Group Photo

On the afternoon of November 6, L'Oréal and Sanofi signed a strategic cooperation agreement at the CIIE, officially launching the "Joining Hands for Love, Reshaping a New Life" public welfare collaboration. CeraVe and Dupixent under Sanofi will integrate their resources to jointly promote public welfare activities focused on patient care and educational outreach for atopic dermatitis. This initiative aims to help atopic dermatitis patients establish a comprehensive disease management mindset while further enhancing public awareness of atopic dermatitis and reinforcing the concept of skin barrier health.

Professor Ma Lin, Department of Dermatology, Beijing Children's Hospital, Capital Medical University

At the signing ceremony, Professor Ma Lin from the Department of Dermatology at Beijing Children's Hospital, Capital Medical University, delivered a speech on "Optimizing the Entire Process of Skin Barrier Management." Professor Ma Lin introduced that skin barrier damage is a key factor in many skin problems. For those with compromised skin barriers, mastering a professional, standardized, and precise skincare routine is crucial. The combination of biologics and moisturizers will help enhance the effectiveness of skin barrier repair.

Ms. Lijuan Xie, General Manager of Sanofi Specialty Care China

Ms. Xie Lijuan, General Manager of Sanofi Specialty Care China, stated: "The journey of Dupixent® at the CIIE is a vivid example of China accelerating the introduction of breakthrough innovative drugs to meet urgent clinical needs. We are not only witnesses but also beneficiaries, having set a record for a single product participating in five CIIEs and gaining approval for five major indications. At this year’s CIIE, we will actively explore new opportunities to not only meet patients' treatment needs but also focus on optimizing their experience. Through our cross-industry collaboration with L'Oréal, we hope that by joining forces in innovative exploration, we can help patients achieve early intervention, timely treatment, and long-term control, bringing vitality to life."

Ms. Zhou Shuangwei, General Manager of L'Oréal China CeraVe Brand

Ms. Zhou Shuangwei, General Manager of L'Oréal China CeraVe brand, stated at the scene: "Health is the first principle of beauty. With the mission of repairing skin barriers, CeraVe's collaboration with Sanofi this time will not only provide more scientifically effective skincare solutions to help address skin issues but also represents the latest public welfare practice in pursuing 'Healthy Beauty' together with ecological partners. Taking advantage of the exchange opportunity at CIIE, we will jointly promote scientific research and health education in the field of dermatology, advocate for a full-process management model for skin barrier health, and work together to broaden the long-term vision of 'Big Health Beauty'."

L'Oréal and Novartis Deepen "Integrated Treatment and Care" Strategic Partnership in Multiple Dimensions, Jointly Advancing Towards the "Beautiful Greater Health" Ecosystem

L'Oréal and Novartis "Integrated Treatment and Care, Building a Beautiful Ecosystem for Greater Health" Strategic Cooperation Upgrade Press Conference Group Photo

Since 2022, CeraVe and Novartis have become strategic partners, taking the lead in initiating scientific research and educational public welfare actions in the field of psoriasis treatment and care. At this year's CIIE, CeraVe and Novartis held a "Treatment and Care Integration for a Beautiful Health Ecosystem" strategic cooperation upgrade press conference, planning to provide more timely and scientific support for groups with damaged skin barriers through various cooperation models such as deepening science popularization education, academic cooperation, and health consultation. The collaboration also aims to promote sustainable development in the field of skin science through closer industrial integration.

Ms. Ma Lan, Vice President of L'Oréal China and General Manager of the Dermatological Beauty Division

At the event, Ms. Ma Lan, Vice President of L'Oréal China and General Manager of the Dermatological Beauty Division, gave an interview to the media, expressing a positive outlook on the shared vision of building an ecosystem for skin barrier health. "Globally, CeraVe aims to provide scientific skincare solutions for all skin types. In the field of dermatological science, CeraVe and Novartis share a common charitable ideal, striving to deeply promote the concept of 'treatment and care integration' across broader grassroots communities in China. This upgraded collaboration marks a new starting point, and we look forward to working with Novartis, along with more young and middle-aged doctors and health industry partners, to extensively advance communication and education in dermatological science, injecting continuous momentum into this ecosystem."

Ms. Tian Yu, Head of Immunotherapy at Novartis China

Ms. Tian Yu, Head of Immunology at Novartis China, pointed out: "For nearly 20 years, Novartis has been deeply committed to the field of dermatology, dedicated to delivering effective, safe, and long-lasting innovative drugs to benefit a broader population of Chinese patients with psoriasis and urticaria. Through strategic collaboration, we will fully leverage Novartis' expertise and experience in the field of immunotherapy, complementing L'Oréal's strengths, to bring more skin care and scientifically-backed treatment concepts to patients with skin diseases, better meeting their treatment needs. We also look forward to injecting new vitality into the development of China’s dermatology industry through cross-sector collaboration, further promoting continuous progress in China’s dermatology field, and contributing to Healthy China 2030."

The CIIE is a platform for openness, cooperation, and exchange, offering a window for global companies to share experiences. As the largest exhibitor in the daily chemical industry for six consecutive editions of the CIIE, L'Oréal has consistently brought globally leading development concepts to the CIIE stage. While conveying its vision of beauty to China and the world, L'Oréal has fully seized opportunities for industrial collaboration and ecosystem building brought by the CIIE, gaining support and inspiration from diverse innovative forces. In the future, L'Oréal China's Dermatological Beauty Division will explore more collaboration opportunities, working with ecosystem partners to promote "Beautiful Health," jointly contributing to high-quality development in the Chinese market, and capturing the world’s attention.